Literature DB >> 16702139

Controlled prescription drug abuse at epidemic level.

.   

Abstract

In July 2005, The National Center on Addiction and Substance Abuse (CASA) at Columbia University announced the results of a study indicating that the number of Americans who abuse controlled prescription drugs has nearly doubled from 7.8 million to 15.1 million from 1992 to 2003 and abuse among teens has more than tripled during that time. A summary of that study and information about the full report are presented.

Mesh:

Year:  2006        PMID: 16702139

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  7 in total

1.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

2.  Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study.

Authors:  Ty S Schepis; Suchitra Krishnan-Sarin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-08       Impact factor: 8.829

Review 3.  Evidence-based pain medicine for primary care physicians.

Authors:  Graves T Owen; Brian M Bruel; C M Schade; Maxim S Eckmann; Erik C Hustak; Mitchell P Engle
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-01-08

4.  Characterizing adolescent prescription misusers: a population-based study.

Authors:  Ty S Schepis; Suchitra Krishnan-Sarin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-07       Impact factor: 8.829

Review 5.  Optimal pain management for patients with cancer in the modern era.

Authors:  Bethann M Scarborough; Cardinale B Smith
Journal:  CA Cancer J Clin       Date:  2018-03-30       Impact factor: 508.702

6.  Outcomes of a Specialized Interdisciplinary Approach for Patients with Cancer with Aberrant Opioid-Related Behavior.

Authors:  Joseph Arthur; Tonya Edwards; Suresh Reddy; Kristy Nguyen; David Hui; Sriram Yennu; Minjeong Park; Diane Liu; Eduardo Bruera
Journal:  Oncologist       Date:  2017-10-11

7.  A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone.

Authors:  Lynn R Webster; Ernest A Kopecky; Michael D Smith; Alison B Fleming
Journal:  Pain Med       Date:  2015-12-14       Impact factor: 3.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.